Nanopore sensors give an osteoarthritis biomarker high sensitivity
William Aryitey |
Over 30 million US adults and nearly nine million UK adults over the age of 45 suffer from osteoarthritis (1)(2). The molecule hyaluronan, also known as hyaluronic acid, plays an essential role in joint physiological functions, giving rise to its use as a biomarker for osteoarthritis. The downside, however, is that the molecule offers neither high sensitivity nor a high dynamic range; consequently, the results it provides are only semiquantitative. Now, researchers from Wake Forest School of Medicine, Cornell University, and the University of Oklahoma Health Sciences Center are looking to boost sensitivity for more quantitative measurements with a solid-state nanopore sensor (3). To find out more about the technique, we spoke with Adam Hall, lead researcher and Assistant Professor of Biomedical Engineering at the Wake Forest School of Biomedical Engineering and Sciences.
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
- Centers for Disease Control and Prevention, “Osteoarthritis (OA)”, (2018). Available at: bit.ly/2uRicCU. Accessed March 29, 2018.
- Arthritis Research UK, “State of musculoskeletal health 2017”, (2017). Available at:
- bit.ly/2IbZE3M. Accessed March 29, 2018.
- F Rivas et al., “Label-free analysis of physiological hyaluronan size distribution with a solid-state nanopore sensor”, Nat Commun, 9, 1037 (2018). PMID: 29531292.